Abstract: The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.

Abstract: There is provided a method and system for generating a program. The method includes detecting a number of steps for performing a task on a computing device and detecting an example relating to each of the steps, wherein the example includes input data and corresponding output data relating to the step. The method also includes, for each example, determining a rule that transforms the input data to the corresponding output data based on cues including textual features within the input data and the corresponding output data. The method further includes generating a program for performing the task based on the rules.

Abstract: Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.

Abstract: Systems and methods described herein relate to creating or modifying multimedia content using sprites. In accordance with some implementations, a method can comprise the operations of: accessing foundational content; receiving a request to apply a sprite effect from a sprite sheet to the foundational content; retrieving the sprite effect from the sprite sheet; and applying the sprite effect to the foundational content according to the request. A sprite sheet can include two or more sprites each of which can be used as an effect in multimedia content, and each of which can be retrieved from the sprite sheet based on coordinates in the sprite sheet. A sprite effect can be an image, an animation, or some other visual-based effect applicable to multimedia content.

Abstract: Disclosed are compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating inflammatory skin diseases.

Abstract: According to certain implementations, systems and methods can access foundational content a user intends to enhance with an effect, the foundational content having an associated timeline that defines a temporal property with respect to the foundational content; apply the effect to the foundational content; and adapt application of the effect according to a multidimensional cue that is configured to trigger an action with respect to the effect, at a temporal position on the timeline when a condition with respect to the context of the foundational content is satisfied.

Abstract: Systems and methods described herein relate to creating or modifying multimedia content using theme-based effects. In accordance with some implementations, a method can comprise the operations of: accessing foundational content having an associated content timeline; receiving a request to apply a theme to the foundational content, wherein the theme includes one or more theme-based effects that relate to the theme; receiving a theme-based effect associated with the theme, wherein the theme-based effect has an associated effect timeline; and applying the theme-based effect to the foundational content according to a set of cues associated with the associated content timeline, wherein applying the theme-based effect comprises adapting the associated effect timeline according to the set of cues while preserving the associated content timeline.

Abstract: Systems and methods described herein relate to creating or modifying multimedia content using theme-based effects. In accordance with some implementations, a method can comprise the operations of: accessing foundational content; receiving a request to apply a theme to the foundational content; receiving a theme-based effect associated with the theme; receiving a licensing parameter of use associated with the theme; and applying the theme-based effect to the foundational content according to the licensing parameter. Themes can include those created by third-party vendors and those created by one or more users of a method or system implementing features described herein. Additionally, use of different themes can vary in cost and/or use limitations, which can be determined according to licensing parameters associated with the themes.

Abstract: Disclosed are compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating inflammatory skin diseases.

Abstract: There is provided a method and system for generating a program. The method includes detecting a number of steps for performing a task on a computing device and detecting an example relating to each of the steps, wherein the example includes input data and corresponding output data relating to the step. The method also includes, for each example, determining a rule that transforms the input data to the corresponding output data based on cues including textual features within the input data and the corresponding output data. The method further includes generating a program for performing the task based on the rules.

Abstract: Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.

Abstract: Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.

Abstract: Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.

Abstract: Disclosed are nitrile derivatives and pharmaceutical compositions comprising nitrile derivatives. The pharmaceutical compositions comprise compounds of the formula I and the pharmaceutically acceptable salts of such compounds. Also disclosed are processes for the preparation of such compounds, intermediates used in the preparation of such compounds, and the uses of such compounds in treating hyperproliferative diseases, inflammatory diseases and viral and bacterial infections and inducing apoptosis in cancer cells.

Abstract: In one aspect, the invention provides a method for recovering particulate material from a component of an electrochemical cell. In another aspect, a method is provided for recovering metal oxide particulate active material. The metal oxide is effectively separated from other cell components and is rendered to a form reusable as an active material for a new electrochemical cell. In still another aspect, a method is provided for recovering lithium metal oxide particulate active material and for regenerating the lithium metal oxide active material back to its initial nominal condition usable as battery grade material in an electrochemical cell. In the latter aspect, the invention provides the capability of treating lithium-deficient metal oxide active material which has become lithium-deficient from repeated cycling in a cell. The lithium-deficient active material is characterized by a lesser lithium content as compared to its nominal initial condition before cycling in a cell.

Abstract: Improved adhesion of an electrode layer with an electrolyte or separator layer can be achieved by substantially preventing polymer binder and plasticizer from absorbing into the substrate. This is achieved by impregnating the substrate with polymer and plasticizer prior to applying the electrode mixture which contains an electrode active material, polymer binder, plasticizer, and solvent onto the substrate. Alternatively, prior to applying the electrode mixture, a coating containing a mixture of polymer and plasticizer is applied unto the substrate to form a coated substrate wherein the coating is substantially pervious to solvent and is substantially impervious to said polymer and plasticizer.

Abstract: Electrochemical cells with improved adhesion of the laminant components can be fabricated by forming an electrode directly on the surface of electrolyte or separator film. This process obviates the need to prepare the anode or cathode in a separate procedure.

Abstract: Superior bonding of an electrode layer to a separator layer can be achieved by applying a coat of pre-lamination solvent on the surface of the electrode and/or separator prior to attachment in fabricating electrochemical cells. The amount of solvent added is effective to dissolve at least a portion of the polymer material on the surface coated so that upon attachment the electrode and separator layers develop excellent adhesion. Preferred pre-lamination solvent has a boiling point higher than about 50.degree. C. at 760 mm of Hg. Preferred pre-lamination solvents include, for example, N,N-dimethyl formamide, N,N-dimethylacetamide, 1,3-dioxolane dioxane, methyl ethyl ketone, and mixtures thereof. Acetone can be included in the pre-lamination solvent.